Research into facial emotion perception in schizophrenia has burgeoned over the past several
decades. The evidence is mixed regarding whether patients with schizophrenia have a …

This study sought to determine the moderators in the treatment effect of repetitive transcranial
magnetic stimulation (rTMS) on negative symptoms in schizophrenia. We performed a meta…

Schizophrenia has a heritability of 60–80% 1 , much of which is attributable to common risk
alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with …

Polygenic risk scores have shown great promise in predicting complex disease risk and will
become more accurate as training sample sizes increase. The standard approach for …

Multisensory temporal integration could be compromised in both autism spectrum disorders
(ASD) and schizophrenia spectrum disorders (SSD) and may play an important role in …

Regulatory and coding variants are known to be enriched with associations identified by
genome-wide association studies (GWASs) of complex disease, but their contributions to trait …

Schizophrenia and bipolar disorder are two distinct diagnoses that share symptomology.
Understanding the genetic factors contributing to the shared and disorder-specific symptoms …

Anhedonia is a hallmark symptom of major depressive disorder (MDD). Preliminary findings
suggest that anhedonia is characterized by reduced reward anticipation and motivation of …

Existing literature on the profile of executive dysfunction in autism spectrum disorder showed
inconsistent results. Age, comorbid attention‐deficit/hyperactivity disorder (ADHD) and …

Background Polygenic scores (PGSs), which assess the genetic risk of individuals for a disease,
are calculated as a weighted count of risk alleles identified in genome-wide association …